| 1 |
Rossi F,Baquero F,Hsueh PR,et al.In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART(Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother,2006,58(1):205-210.
|
| 2 |
Hsueh PR,Hawkey PM.Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. Int J Antimicrob Agents. 2007,30(2):129-133.
|
| 3 |
Tellado JM, Sen SS, Caloto MT, et al. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis,2007,39(11-12):947-955.
|
| 4 |
Sturkenboom MC, Goettsch WG, Picelli G, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol, 2005, 60(4):438-443.
|
| 5 |
肖永红,王进.2006-2007 Mohnarin 细菌耐药监测报告.天津科学技术出版社,2008,24-27.
|
| 6 |
Mazuski JE,Sawyer RG,Nathens AB,et al.The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections:evidence for the recommendations.Surg Infect(Larchmt),2002,3(3):175-233.
|
| 7 |
Salomkin JS,Mazuki JE,Baron EJ,et al.Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis,2003,37(8):997-1005.
|
| 8 |
Infectious Diseases Society of Taiwan. Guideline for antimicrobial ther apy of intra-abdominal infection in adults.J Microbiol Immunol Infect,2008,41(3):279-281.
|
| 9 |
冷希圣.复杂性腹腔感染的莫西沙星单药治疗.中华普通外科杂志,2009,24(3):263.
|